SCHEMBL20312333

SCHEMBL20312333

COB(OC)c1ccc(N(C)C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.52
▸ TSHR P16473 6/20 0.52
▸ ALOX15 P16050 3/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ MAPK1 P28482 5/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ SLC2A1 P11166 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2A13 Q16696 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ APP P05067 2/20 0.37
▸ CALM1 P0DP23 1/20 0.37
▸ CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15744762 0.82 CA2 (0.38) —
SCHEMBL20312351 0.76 ALDH1A1 (0.46) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL20312372 0.76 ALDH1A1 (0.46) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL1507038 0.74 ALDH1A1 (0.44) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL20312336 0.74 ALDH1A1 (0.45) ALDH1A1TSHRALOX15HSD17B10TP53
SCHEMBL18124820 0.74 CA1 (0.35) MAPK1TP53SMN1; SMN2
SCHEMBL18125392 0.74 CA1 (0.35) MAPK1TP53SMN1; SMN2
SCHEMBL65261 0.72 ALDH1A1 (1.00) ALDH1A1TSHRALOX15HSD17B10MAPK1
SCHEMBL5953326 0.72 CA2 (0.48) ALDH1A1TSHRCYP3A4TDP1MAPT
SCHEMBL13426909 0.72 ALDH1A1 (0.61) ALDH1A1TSHRALOX15HSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate TOKYO OHKA KOGYO CO, LTD. (JP) 2019-12-10 — — US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 — — US disclosed
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180182624-A1 IMPURITY DIFFUSION AGENT COMPOSITION AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE SLC43A1, SAMHD1, SNRPD2 ALDH1A1 2704/4885TSHR 4456/4885ALOX15 4044/4885
US-10504732-B2 Impurity diffusion agent composition and method for manufacturing semiconductor substrate SLC43A1, SAMHD1, SNRPD2 ALDH1A1 2704/4885TSHR 4456/4885ALOX15 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback